Courtney M. Lappas
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Courtney M. Lappas has a total of 21 co-authors. Here are the top co-authors by number of shared publications:
Nicholas T. Lappas
3 shared publications- Amanda J. Dillard
Department of Psychology, Grand Valley State University, Allendale, MI, USA
2 shared publications Justin N. Weilnau
Department of Biology, Lebanon Valley College, Annville, PA 17003, USA
2 shared publicationsVeronica J. Chehata
Department of Biology Lebanon Valley College Annville PA 17003 USA
2 shared publicationsAnderson L. Marsh
Department Chemistry Lebanon Valley College Annville PA 17003 USA
1 shared publication- Brandon G. Roy
Section of Plant Pathology and Plant-Microbe Biology, School of Integrative Plant Science, Cornell University, Cornell AgriTech, Geneva, NY 14456, U.S.A.
1 shared publication
Latest Publications
- 1 January 2023
- Published by Hogrefe Publishing Group in European Journal of Health Psychology
- Vol. 30 (1) , 40-47
Do Physicians Prefer Natural Drugs?
Background: There is a bias for natural versus synthetic drugs in general populations. Aims: We investigated whether physicians who have advanced medical and scientific training and routinely prescribe drugs exhibit this bias. Methods: Physicians and non-physicians were presented with a hypothetical medical situation in which pharmacological therapy was required. Participants were asked if they would prefer a natural or synthetic drug for treatment. Physicians were also asked which drug they would prescribe to a patient. Results: In a forced-choice paradigm, non-physicians (87.5%) and physicians (79.2%) had an equally strong bias for the natural drug, with physicians (74.3%) also preferring the natural drug for patients. When a 9-point drug choice scale was used, including a “no preference” choice (5), non-physicians ( M = 6.91) and physicians ( M = 5.41) again showed a preference for the natural drug compared to the mid-point of the scale, but the non-physicians’ bias was stronger. Physicians no longer preferred the natural drug for patients ( M = 5.15). Limitations: The participants do not represent a random sample and therefore may not represent physicians/non-physicians in general. Additionally, the responses were hypothetical and may not represent behavior in actual medical contexts. Conclusion: These data indicate that physicians and non-physicians exhibit a bias for natural drugs, with physicians also demonstrating a bias for prescribing natural drugs. However, the bias is reduced in physicians compared to non-physicians when a “no preference” option is available, suggesting that advanced medical and/or scientific training may be beneficial in minimizing this bias.
- 1 January 2023
- Published by Hogrefe Publishing Group in European Journal of Health Psychology
- Vol. 30 (1) , 40-47
Do Physicians Prefer Natural Drugs?
Background: There is a bias for natural versus synthetic drugs in general populations. Aims: We investigated whether physicians who have advanced medical and scientific training and routinely prescribe drugs exhibit this bias. Methods: Physicians and non-physicians were presented with a hypothetical medical situation in which pharmacological therapy was required. Participants were asked if they would prefer a natural or synthetic drug for treatment. Physicians were also asked which drug they would prescribe to a patient. Results: In a forced-choice paradigm, non-physicians (87.5%) and physicians (79.2%) had an equally strong bias for the natural drug, with physicians (74.3%) also preferring the natural drug for patients. When a 9-point drug choice scale was used, including a “no preference” choice (5), non-physicians ( M = 6.91) and physicians ( M = 5.41) again showed a preference for the natural drug compared to the mid-point of the scale, but the non-physicians’ bias was stronger. Physicians no longer preferred the natural drug for patients ( M = 5.15). Limitations: The participants do not represent a random sample and therefore may not represent physicians/non-physicians in general. Additionally, the responses were hypothetical and may not represent behavior in actual medical contexts. Conclusion: These data indicate that physicians and non-physicians exhibit a bias for natural drugs, with physicians also demonstrating a bias for prescribing natural drugs. However, the bias is reduced in physicians compared to non-physicians when a “no preference” option is available, suggesting that advanced medical and/or scientific training may be beneficial in minimizing this bias.
- 29 October 2021
- Published by Elsevier
- p. 3-23
Principles of Pharmacokinetics
- Open Access
- 3 March 2021
- Published by Oxford University Press (OUP) in Journal of Public Health
- Vol. 44 (3) , 713-715
Predictors of the intention to receive a SARS-CoV-2 vaccine
Background: It is imperative to understand the predictors of vaccine hesitancy for current and future pandemics. Methods: A representative sample (age, race & gender) of 1054 US adults was collected in October 2020 to examine the predictors of vaccine hesitancy. Participants were asked several questions including their intention to receive a vaccine for the novel coronavirus. Results: Predictors significantly associated with a greater intention to receive a COVID-19 vaccine included greater perceived feelings of vulnerability to COVID-19, having received a flu vaccination at the time the question was asked, more liberal political orientation, non-Black race, male gender, and a lower naturalness bias. Conclusions: Vaccines are essential for mitigating current and future pandemics. Multiple strategies are important in encouraging people to be vaccinated and the predictors highlighted here and elsewhere are likely to be useful targets.
- 3 March 2021
- Published by Oxford University Press (OUP) in Journal of Public Health
- Vol. 44 (3) , 713-715
Open AccessPredictors of the intention to receive a SARS-CoV-2 vaccine
Background: It is imperative to understand the predictors of vaccine hesitancy for current and future pandemics. Methods: A representative sample (age, race & gender) of 1054 US adults was collected in October 2020 to examine the predictors of vaccine hesitancy. Participants were asked several questions including their intention to receive a vaccine for the novel coronavirus. Results: Predictors significantly associated with a greater intention to receive a COVID-19 vaccine included greater perceived feelings of vulnerability to COVID-19, having received a flu vaccination at the time the question was asked, more liberal political orientation, non-Black race, male gender, and a lower naturalness bias. Conclusions: Vaccines are essential for mitigating current and future pandemics. Multiple strategies are important in encouraging people to be vaccinated and the predictors highlighted here and elsewhere are likely to be useful targets.
- 14 October 2020
- Published by Wiley in Biochemistry and Molecular Biology Education
- Vol. 49 (3) , 475-482
Utilizing loop‐mediated isothermal amplification to detect the presence of Escherichia coli: An inquiry‐driven undergraduate laboratory module
The amplification of nucleic acids is a fundamental tool utilized in various scientific disciplines, including Molecular Biology, Immunology, Microbiology, and Genetics. However, due to the time and technology required for traditional polymerase chain reaction and its derivatives, it is not always possible to include such methodologies in undergraduate laboratory curricula. Loop‐mediated isothermal amplification (LAMP), a technology that has become increasingly utilized in a variety of laboratory and field settings during the past two decades, is an alternate method of nucleic acid amplification that is rapid, sensitive, and performed under isothermal conditions. We describe an adaptable, inquiry‐driven laboratory module that is focused on the detection of Escherichia coli DNA via LAMP amplification. The main objectives of the module are to introduce students to the principles and protocols of LAMP, to help students develop the ability to apply the scientific method to scientific questions, to guide students as they develop the ability to identify the most appropriate methodology to use in the investigation of scientific questions, and to train students to critically evaluate scientific data, theories, and principles and to articulate their evaluations in both written and oral formats.
- 14 October 2020
- Published by Wiley in Biochemistry and Molecular Biology Education
- Vol. 49 (3) , 475-482
Utilizing loop‐mediated isothermal amplification to detect the presence of Escherichia coli: An inquiry‐driven undergraduate laboratory module
The amplification of nucleic acids is a fundamental tool utilized in various scientific disciplines, including Molecular Biology, Immunology, Microbiology, and Genetics. However, due to the time and technology required for traditional polymerase chain reaction and its derivatives, it is not always possible to include such methodologies in undergraduate laboratory curricula. Loop‐mediated isothermal amplification (LAMP), a technology that has become increasingly utilized in a variety of laboratory and field settings during the past two decades, is an alternate method of nucleic acid amplification that is rapid, sensitive, and performed under isothermal conditions. We describe an adaptable, inquiry‐driven laboratory module that is focused on the detection of Escherichia coli DNA via LAMP amplification. The main objectives of the module are to introduce students to the principles and protocols of LAMP, to help students develop the ability to apply the scientific method to scientific questions, to guide students as they develop the ability to identify the most appropriate methodology to use in the investigation of scientific questions, and to train students to critically evaluate scientific data, theories, and principles and to articulate their evaluations in both written and oral formats.
- 1 November 2015
- Published by Elsevier in Food and Chemical Toxicology
- Vol. 85, 78-83
The immunomodulatory effects of titanium dioxide and silver nanoparticles
- 1 November 2015
- Published by Elsevier in Food and Chemical Toxicology
- Vol. 85, 78-83
The immunomodulatory effects of titanium dioxide and silver nanoparticles
- 12 May 2014
- Published by Springer Nature in Cellular & Molecular Immunology
- Vol. 12 (1) , 107-112
The plant hormone zeatin riboside inhibits T lymphocyte activity via adenosine A2A receptor activation
Cytokinins are plant hormones that play an integral role in multiple aspects of plant growth and development. The biological functions of cytokinins in mammalian systems are, however, largely uncharacterized. The naturally occurring cytokinin zeatin riboside has recently been demonstrated to activate the mammalian adenosine A2A receptor, which is broadly expressed by various cell types including immune system cells, with the activation of the A2AR playing a role in the regulation of cells involved in both innate and adaptive immunity. We show for the first time that zeatin riboside modulates mammalian immune system activity via an A2AR-dependent mechanism. Specifically, zeatin riboside treatment induces the production of cyclic adenosine monophosphate (cAMP) by T lymphocytes and inhibits the production by CD3+CD4+ T cells of interferon (IFN)-γ, IL-2, tumor-necrosis factor (TNF)-α, IL-4 and IL-13, and the production by CD3+CD8+ T cells of IFN-γ, IL-2 and TNF-α. Additionally, the upregulation of CD25, CD69 and CD40L by activated T lymphocytes is modulated by zeatin riboside. Zeatin riboside treatment also potently inhibits thioglycollate-induced peritoneal leukocytosis. The immunomodulatory activities of zeatin riboside are blocked by co-treatment with the selective A2AR antagonist ZM241385. These data suggest that zeatin riboside possesses therapeutic potential as a mammalian immunomodulatory agent.
- 12 May 2014
- Published by Springer Nature in Cellular & Molecular Immunology
- Vol. 12 (1) , 107-112
The plant hormone zeatin riboside inhibits T lymphocyte activity via adenosine A2A receptor activation
Cytokinins are plant hormones that play an integral role in multiple aspects of plant growth and development. The biological functions of cytokinins in mammalian systems are, however, largely uncharacterized. The naturally occurring cytokinin zeatin riboside has recently been demonstrated to activate the mammalian adenosine A2A receptor, which is broadly expressed by various cell types including immune system cells, with the activation of the A2AR playing a role in the regulation of cells involved in both innate and adaptive immunity. We show for the first time that zeatin riboside modulates mammalian immune system activity via an A2AR-dependent mechanism. Specifically, zeatin riboside treatment induces the production of cyclic adenosine monophosphate (cAMP) by T lymphocytes and inhibits the production by CD3+CD4+ T cells of interferon (IFN)-γ, IL-2, tumor-necrosis factor (TNF)-α, IL-4 and IL-13, and the production by CD3+CD8+ T cells of IFN-γ, IL-2 and TNF-α. Additionally, the upregulation of CD25, CD69 and CD40L by activated T lymphocytes is modulated by zeatin riboside. Zeatin riboside treatment also potently inhibits thioglycollate-induced peritoneal leukocytosis. The immunomodulatory activities of zeatin riboside are blocked by co-treatment with the selective A2AR antagonist ZM241385. These data suggest that zeatin riboside possesses therapeutic potential as a mammalian immunomodulatory agent.
- 14 September 2012
- Published by Wiley in Journal of Applied Toxicology
- Vol. 33 (3) , 227-237
ZnS nanocrystal cytotoxicity is influenced by capping agent chemical structure and duration of time in suspension
As a result of their characteristic physical and optical properties, including their size, intense fluorescence, broad excitation, narrow emission and resistance to photobleaching, semiconductor nanocrystals are potentially useful for a variety of biological applications including molecular imaging, live‐cell labeling, photodynamic therapy and targeted drug delivery. In this study, zinc sulfide (ZnS) semiconductor nanocrystals were synthesized in the 3 to 4 nm size range with selected capping agents intended to protect the nanocrystal core and increase its biological compatibility. We show that the biocompatibility of ZnS nanocrystals with primary murine splenocytes is influenced by the chemical structure of the outer capping agent on the nanocrystal. Additionally, the cytotoxicity of ZnS nanocrystals increases markedly as a function of time spent in suspension in phosphate‐buffered saline (PBS). These data suggest that the potential therapeutic and/or biological use of ZnS nanocrystals is inherently dependent upon the proper choice of capping agent, as well as the conditions of nanocrystal preparation and storage. Copyright © 2012 John Wiley & Sons, Ltd.
- 14 September 2012
- Published by Wiley in Journal of Applied Toxicology
- Vol. 33 (3) , 227-237
ZnS nanocrystal cytotoxicity is influenced by capping agent chemical structure and duration of time in suspension
As a result of their characteristic physical and optical properties, including their size, intense fluorescence, broad excitation, narrow emission and resistance to photobleaching, semiconductor nanocrystals are potentially useful for a variety of biological applications including molecular imaging, live‐cell labeling, photodynamic therapy and targeted drug delivery. In this study, zinc sulfide (ZnS) semiconductor nanocrystals were synthesized in the 3 to 4 nm size range with selected capping agents intended to protect the nanocrystal core and increase its biological compatibility. We show that the biocompatibility of ZnS nanocrystals with primary murine splenocytes is influenced by the chemical structure of the outer capping agent on the nanocrystal. Additionally, the cytotoxicity of ZnS nanocrystals increases markedly as a function of time spent in suspension in phosphate‐buffered saline (PBS). These data suggest that the potential therapeutic and/or biological use of ZnS nanocrystals is inherently dependent upon the proper choice of capping agent, as well as the conditions of nanocrystal preparation and storage. Copyright © 2012 John Wiley & Sons, Ltd.
- 1 September 2012
- Published by Elsevier in Cellular Immunology
- Vol. 279 (1) , 30-41
d-Limonene modulates T lymphocyte activity and viability
- 1 September 2012
- Published by Elsevier in Cellular Immunology
- Vol. 279 (1) , 30-41
d-Limonene modulates T lymphocyte activity and viability
- 31 December 2011
- Published by Elsevier in Cellular Immunology
- Vol. 267 (1) , 39-49
Adenosine A2A receptor activation limits chronic granulomatous disease-induced hyperinflammation
- 31 December 2011
- Published by Elsevier in Cellular Immunology
- Vol. 267 (1) , 39-49
Adenosine A2A receptor activation limits chronic granulomatous disease-induced hyperinflammation